Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
- Previous Close
19.97 - Open
19.40 - Bid 21.97 x --
- Ask --
- Day's Range
20.50 - 21.97 - 52 Week Range
16.49 - 44.66 - Volume
4,397,190 - Avg. Volume
1,834,265 - Market Cap (intraday)
3.507B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
16.40 - EPS (TTM)
1.34 - Earnings Date --
- Forward Dividend & Yield 0.50 (2.50%)
- Ex-Dividend Date May 24, 2023
- 1y Target Est
--
Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines. In addition, it provides medical intermediates, including 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, 3-mercapto-1-propanol, paeonol, sodium paeonol sulfonate, methyl 2,3-dichlorobenzylidene acetoacetate, n-[(1,4-benzodioxan-2-yl) carbonyl piperazine hydrochloride, alogliptin benzoate, roflumilast, and zofenopril calcium; plant extract products, such as clove oil and campanula extracts; and pieces that consist of poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. Further, the company offers central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, external skin drugs and other fields. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.
www.lifeonapi.comRelated News
Performance Overview: 003020.SZ
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 003020.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 003020.SZ
Valuation Measures
Market Cap
3.19B
Enterprise Value
2.73B
Trailing P/E
14.92
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.42
Price/Book (mrq)
1.99
Enterprise Value/Revenue
1.23
Enterprise Value/EBITDA
11.49
Financial Highlights
Profitability and Income Statement
Profit Margin
9.52%
Return on Assets (ttm)
5.33%
Return on Equity (ttm)
13.39%
Revenue (ttm)
2.21B
Net Income Avi to Common (ttm)
210.43M
Diluted EPS (ttm)
1.34
Balance Sheet and Cash Flow
Total Cash (mrq)
469.19M
Total Debt/Equity (mrq)
0.49%
Levered Free Cash Flow (ttm)
-45.48M
Company Insights: 003020.SZ
003020.SZ does not have Company Insights